These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8806176)
21. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. Liu Y; Chen JJ; Gao Q; Dalal S; Hong Y; Mansur CP; Band V; Androphy EJ J Virol; 1999 Sep; 73(9):7297-307. PubMed ID: 10438818 [TBL] [Abstract][Full Text] [Related]
22. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343 [TBL] [Abstract][Full Text] [Related]
23. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422 [TBL] [Abstract][Full Text] [Related]
24. Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance. Brimer N; Vande Pol SB J Virol; 2014 Mar; 88(5):3027-30. PubMed ID: 24352452 [TBL] [Abstract][Full Text] [Related]
25. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6. Gardiol D; Banks L J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244 [TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Kumar A; Zhao Y; Meng G; Zeng M; Srinivasan S; Delmolino LM; Gao Q; Dimri G; Weber GF; Wazer DE; Band H; Band V Mol Cell Biol; 2002 Aug; 22(16):5801-12. PubMed ID: 12138191 [TBL] [Abstract][Full Text] [Related]
27. Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation. Isaacs JS; Barrett JC; Weissman BE Mol Carcinog; 1999 Jan; 24(1):70-7. PubMed ID: 10029413 [TBL] [Abstract][Full Text] [Related]
28. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. Crook T; Ludwig RL; Marston NJ; Willkomm D; Vousden KH Virology; 1996 Mar; 217(1):285-92. PubMed ID: 8599213 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. Tan TM; Gloss B; Bernard HU; Ting RC J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152 [TBL] [Abstract][Full Text] [Related]
30. The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies. Matlashewski G; Banks L; Wu-Liao J; Spence P; Pim D; Crawford L J Gen Virol; 1986 Sep; 67 ( Pt 9)():1909-16. PubMed ID: 3018129 [TBL] [Abstract][Full Text] [Related]
31. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Huibregtse JM; Scheffner M; Howley PM Mol Cell Biol; 1993 Aug; 13(8):4918-27. PubMed ID: 8393140 [TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. Dalal S; Gao Q; Androphy EJ; Band V J Virol; 1996 Feb; 70(2):683-8. PubMed ID: 8551603 [TBL] [Abstract][Full Text] [Related]
33. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Lipari F; McGibbon GA; Wardrop E; Cordingley MG Biochemistry; 2001 Feb; 40(5):1196-204. PubMed ID: 11170444 [TBL] [Abstract][Full Text] [Related]
34. E6 protein of human papillomavirus 16 (HPV16) expressed in Escherichia coli sans a stretch of hydrophobic amino acids, enables purification of GST-ΔE6 in the soluble form and retains the binding ability to p53. Verma RR; Sriraman R; Rana SK; Ponnanna NM; Rajendar B; Ghantasala P; Rajendra L; Matur RV; Srinivasan VA Protein Expr Purif; 2013 Nov; 92(1):41-7. PubMed ID: 24012792 [TBL] [Abstract][Full Text] [Related]
35. p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16. Akutsu N; Shirasawa H; Asano T; Isono K; Simizu B J Gen Virol; 1996 Mar; 77 ( Pt 3)():459-63. PubMed ID: 8601782 [TBL] [Abstract][Full Text] [Related]
36. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. Tao M; Kruhlak M; Xia S; Androphy E; Zheng ZM J Virol; 2003 Dec; 77(24):13232-47. PubMed ID: 14645580 [TBL] [Abstract][Full Text] [Related]
37. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins. Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052 [TBL] [Abstract][Full Text] [Related]
38. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Alfandari J; Shnitman Magal S; Jackman A; Schlegel R; Gonen P; Sherman L Virology; 1999 May; 257(2):383-96. PubMed ID: 10329549 [TBL] [Abstract][Full Text] [Related]
39. Identification of a region of p53 that confers lability. Li X; Coffino P J Biol Chem; 1996 Feb; 271(8):4447-51. PubMed ID: 8626797 [TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein. Sherman L; Alloul N Virology; 1992 Dec; 191(2):953-9. PubMed ID: 1333130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]